These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28215220)

  • 1. Methicillin-Resistant Staphylococcus aureus: A Pharmacotherapy Primer.
    Molloy L
    J Pediatr Health Care; 2017; 31(2):246-256. PubMed ID: 28215220
    [No Abstract]   [Full Text] [Related]  

  • 2. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
    Jongsma K; Joson J; Heidari A
    J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
    [No Abstract]   [Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus infections.
    Taylor AR
    Prim Care; 2013 Sep; 40(3):637-54. PubMed ID: 23958361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Daptomycin for the treatment of infective endocarditis: When do we use it?].
    Şimşek Yavuz S
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):303-307. PubMed ID: 28595198
    [No Abstract]   [Full Text] [Related]  

  • 6. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
    Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
    J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant
    Lv C; Lv J; Liu Y; Liu Q; Zou D
    Int J Immunopathol Pharmacol; 2020; 34():2058738420925713. PubMed ID: 32567423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
    Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
    J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy.
    Oltolini C; Castiglioni B; Tassan Din C; Castiglioni A; Ossi C; La Canna G; Pajoro U; Scarpellini P
    Int J Antimicrob Agents; 2016 Jun; 47(6):502-4. PubMed ID: 27211210
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
    Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
    Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.
    Lee JY; Howden BP
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):855-69. PubMed ID: 25947636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approaches for pediatric patients with osteomyelitis: current issues and answers.
    Geist A; Kuhn R
    Orthopedics; 2009 Aug; 32(8):573. PubMed ID: 19681544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of MRSA infections].
    Borde JP; Kern WV
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial options in the treatment of adult staphylococcal bone and joint infections in an era of drug shortages.
    Mruk AL; Record KE
    Orthopedics; 2012 May; 35(5):401-7. PubMed ID: 22588396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
    Liu C; Bayer A; Cosgrove SE; Daum RS; Fridkin SK; Gorwitz RJ; Kaplan SL; Karchmer AW; Levine DP; Murray BE; J Rybak M; Talan DA; Chambers HF;
    Clin Infect Dis; 2011 Feb; 52(3):e18-55. PubMed ID: 21208910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: a clinical audit.
    Thomas R; Ferguson J; Coombs G; Gibson PG
    Respirology; 2011 Aug; 16(6):926-31. PubMed ID: 21382130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of vertebral osteomyelitis.
    Gelfand MS; Cleveland KO
    J Infect; 2014 Mar; 68(3):299-300. PubMed ID: 24247065
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric acute osteomyelitis in the postvaccine, methicillin-resistant Staphylococcus aureus era.
    Ratnayake K; Davis AJ; Brown L; Young TP
    Am J Emerg Med; 2015 Oct; 33(10):1420-4. PubMed ID: 26298052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.